fluconazole has been researched along with Koch's Disease in 16 studies
Fluconazole: Triazole antifungal agent that is used to treat oropharyngeal CANDIDIASIS and cryptococcal MENINGITIS in AIDS.
fluconazole : A member of the class of triazoles that is propan-2-ol substituted at position 1 and 3 by 1H-1,2,4-triazol-1-yl groups and at position 2 by a 2,4-difluorophenyl group. It is an antifungal drug used for the treatment of mucosal candidiasis and for systemic infections including systemic candidiasis, coccidioidomycosis, and cryptococcosis.
Excerpt | Relevance | Reference |
---|---|---|
" Blood samples were collected from the first 12 patients in each group and pharmacokinetic parameters for fluconazole were calculated." | 2.71 | Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS. ( Panomvana Na Ayudhya, D; Tansuphaswadikul, S; Thanompuangseree, N, 2004) |
"Pulmonary cryptococcosis is rare in immunocompetent individuals." | 1.62 | It is not always Tuberculosis! A case of pulmonary cryptococcosis in an immunocompetent child in Uganda. ( Kasirye, P; Kiguli, S; Musoke, P; Nakatudde, I, 2021) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (12.50) | 18.7374 |
1990's | 4 (25.00) | 18.2507 |
2000's | 3 (18.75) | 29.6817 |
2010's | 6 (37.50) | 24.3611 |
2020's | 1 (6.25) | 2.80 |
Authors | Studies |
---|---|
Krátký, M | 1 |
Bősze, S | 1 |
Baranyai, Z | 1 |
Szabó, I | 1 |
Stolaříková, J | 1 |
Paraskevopoulos, G | 1 |
Vinšová, J | 1 |
Ramprasad, J | 1 |
Nayak, N | 1 |
Dalimba, U | 1 |
Yogeeswari, P | 1 |
Sriram, D | 1 |
Peethambar, SK | 1 |
Achur, R | 1 |
Kumar, HS | 1 |
Kishk, SM | 1 |
McLean, KJ | 1 |
Sood, S | 1 |
Helal, MA | 1 |
Gomaa, MS | 1 |
Salama, I | 1 |
Mostafa, SM | 1 |
de Carvalho, LPS | 1 |
Munro, AW | 1 |
Simons, C | 1 |
Nakatudde, I | 1 |
Kasirye, P | 1 |
Kiguli, S | 1 |
Musoke, P | 1 |
Morare, NMT | 1 |
Rose, DM | 1 |
Appels, O | 1 |
Rajasingham, R | 1 |
Meya, DB | 1 |
Boulware, DR | 1 |
Ren, X | 1 |
Liu, W | 1 |
Liu, Y | 1 |
Kingkaew, N | 1 |
Sangtong, B | 1 |
Amnuaiphon, W | 1 |
Jongpaibulpatana, J | 1 |
Mankatittham, W | 1 |
Akksilp, S | 1 |
Sirinak, C | 1 |
Nateniyom, S | 1 |
Burapat, C | 1 |
Kittikraisak, W | 1 |
Monkongdee, P | 1 |
Varma, JK | 1 |
MESCOLINI, G | 1 |
MARINO, C | 1 |
Panomvana Na Ayudhya, D | 1 |
Thanompuangseree, N | 1 |
Tansuphaswadikul, S | 1 |
Kokturk, N | 1 |
Ekim, N | 1 |
Kervan, F | 1 |
Arman, D | 1 |
Memis, L | 1 |
Caglar, K | 1 |
Kalkanci, A | 1 |
Demircan, S | 1 |
Kurul, C | 1 |
Akyurek, N | 1 |
Teira, R | 1 |
Ben Hamida, M | 1 |
Bedrossian, J | 1 |
Pruna, A | 1 |
Fouqueray, B | 1 |
Metivier, F | 1 |
Idatte, JM | 1 |
Bowersox, J | 1 |
2 trials available for fluconazole and Koch's Disease
Article | Year |
---|---|
Effects of fluconazole on the clinical outcome and immune response in fungal co-infected tuberculosis patients.
Topics: Aged; Aged, 80 and over; Body Mass Index; Chemokine CXCL10; Chemokine CXCL11; Chemokine CXCL9; Chemo | 2018 |
Effect of rifampicin on the pharmacokinetics of fluconazole in patients with AIDS.
Topics: Acquired Immunodeficiency Syndrome; Adult; Antibiotics, Antitubercular; Antifungal Agents; Area Unde | 2004 |
14 other studies available for fluconazole and Koch's Disease
Article | Year |
---|---|
Synthesis and in vitro biological evaluation of 2-(phenylcarbamoyl)phenyl 4-substituted benzoates.
Topics: Anti-Bacterial Agents; Antifungal Agents; Bacteria; Bacterial Infections; Benzoates; Fungi; Humans; | 2015 |
Synthesis and biological evaluation of new imidazo[2,1-b][1,3,4]thiadiazole-benzimidazole derivatives.
Topics: Animals; Antifungal Agents; Antioxidants; Antitubercular Agents; Benzimidazoles; Cell Survival; Chlo | 2015 |
Synthesis and biological evaluation of novel cYY analogues targeting Mycobacterium tuberculosis CYP121A1.
Topics: Antitubercular Agents; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Dipeptide | 2019 |
It is not always Tuberculosis! A case of pulmonary cryptococcosis in an immunocompetent child in Uganda.
Topics: Antifungal Agents; Child; Cryptococcosis; Fluconazole; Humans; Tuberculosis; Uganda | 2021 |
Oesophageal tuberculosis with concomitant candidiasis: a rare cause of dysphagia.
Topics: Antifungal Agents; Antitubercular Agents; Candidiasis; Deglutition Disorders; Esophageal Diseases; F | 2019 |
Are fluconazole or sertraline dose adjustments necessary with concomitant rifampin?
Topics: AIDS-Related Opportunistic Infections; Anti-HIV Agents; Antibiotics, Antitubercular; Antifungal Agen | 2018 |
HIV-associated extrapulmonary tuberculosis in Thailand: epidemiology and risk factors for death.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-HIV Agents; Anti-Infective Agents; Cohort Studies | 2009 |
[Topography and morphology of zonal pulmonary densities caused by tuberculous primary infection (forms with favorable evolution); clinico-pathogenetic and therapeutic considerations].
Topics: Fluconazole; Humans; Lung; Radiography; Tuberculosis; Tuberculosis, Pulmonary | 1957 |
[Orthology of the bronchial tree and zonal topography of the lung of the adult rabbit, and research on the development of experimental tuberculous alterations in reference to the systematics of the pulmonary zones].
Topics: Animals; Bronchi; Fluconazole; Lung; Rabbits; Thoracic Cavity; Trees; Tuberculosis | 1950 |
Disseminated cryptococcosis in a human immunodeficiency virus-negative patient: a case report.
Topics: Antifungal Agents; Antitubercular Agents; Cryptococcosis; Cryptococcus neoformans; Female; Fluconazo | 2005 |
Drugs for AIDS and associated infections.
Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Amphotericin B; Antifunga | 1995 |
[Treatment and prevention of main infections associated with HIV].
Topics: Adrenal Cortex Hormones; Amphotericin B; Controlled Clinical Trials as Topic; Cryptococcosis; Flucon | 1994 |
Fungal mycotic aneurysms and visceral infection due to Scedosporium apiospermum in a kidney transplant patient.
Topics: Antitubercular Agents; Aortic Aneurysm, Abdominal; Candidiasis; Drug Therapy, Combination; Fluconazo | 1993 |
CPCRA researchers present OI studies at Vancouver.
Topics: Adult; AIDS-Related Opportunistic Infections; Anti-Bacterial Agents; Anti-Infective Agents; Antifung | 1996 |